Voyager Therapeutics, Inc.VYGRNASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$0.53
Net Income/Share$-2.16
Operating CF/Share$-1.99
Free CF/Share$-2.02
Cash/Share$3.55
Book Value/Share$3.74
Tangible Book/Share$3.74
Equity/Share$3.74
Interest Debt/Share$0.65
CapEx/Share$0.04
Dividend/Share$0.00
Valuation
Market Cap$222.40M
Enterprise Value$215.64M
P/E Ratio-1.86P/S Ratio7.10P/OCF Ratio-2.01
P/FCF Ratio-1.87
P/B Ratio1.07P/TB Ratio1.07
EV/Sales6.89EV/EBITDA-1.62
Graham Valuation
Graham Number--
Graham Net-Net$2.44
Profitability
Earnings Yield-53.90%FCF Yield-53.44%ROE-48.94%ROIC-53.79%Return on Tangible Assets-43.97%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF-1.82%
CapEx/Revenue6.79%
CapEx/Depreciation0.95
SBC/Revenue36.86%
SG&A/Revenue118.86%
R&D/Revenue428.87%
Liquidity & Solvency
Debt/Equity0.17Debt/Assets0.13Debt/Market Cap0.17
Net Debt/EBITDA0.05
Current Ratio6.19Interest Coverage0.00xIncome Quality0.92Efficiency
Days Sales Outstanding47 days
Days Payables Outstanding0 days
Days Inventory0 days
Receivables Turnover7.76x
Payables Turnover0.00x
Inventory Turnover0.00x
Capital Structure
Tangible Assets$219.82M
Working Capital$184.09M
Invested Capital$227.12M
Intangibles/Assets0.00%